Imaging: Advancing Biomarker Research for Alzheimer's Disease Diagnosis In an article published in the latest edition of the Journal for Clinical Studies, IXICO’s Chief Scientific Officer Robin Wolz outlines how data from the landmark Bio-Hermes study, sponsored by the Global Alzheimer's Platform Foundation (GAP) and supported by IXICO as imaging partner, can help better understand the…
Alzheimer's disease is a complex neurodegenerative disorder that affects millions of people worldwide. While there is no cure for the disease, ongoing research efforts have led to significant advancements in our understanding of the underlying mechanisms that drive the disease.
Multiple Sclerosis (MS) is an unpredictable neurological condition which affects the brain and spinal cord, potentially causing a wide range of symptoms including problems with vision, arm or leg movements, sensation, and balance. Multiple Sclerosis (MS) is the most common autoimmune disorder of the Central Nervous System (CNS), affecting around 2.